Skip to Main Content

Paper Details

Anti-leukaemic activity of the TYK2 selective inhibitor NDI-031301 in T-cell acute lymphoblastic leukaemia.
Br J Haematol
26
2017
Author NameAffiliation
David M WeinstockDana-Farber Cancer Institute, Harvard Medical School
Alex LookDana-Farber Cancer Institute, Harvard Medical School
Alex LookBoston Children's Hospital
  • 1 - 3

Datasets

Release 1.2